Author:
Scialla Julia J.,Kendrick Jessica,Uribarri Jaime,Kovesdy Csaba P.,Gutiérrez Orlando M.,Jimenez Elizabeth Yakes,Kramer Holly J.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Reference69 articles.
1. Phosphate-binder use in US dialysis patients: prevalence, costs, evidence, and policies;St Peter;Am J Kidney Dis,2018
2. KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD);Kidney Int Suppl,2009
3. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease;Isakova;Kidney Int,2011
4. Update on chronic kidney disease mineral and bone disorder in cardiovascular disease;Lunyera;Semin Nephrol,2018
5. Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease;Felsenfeld;Semin Dial,2015
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献